In addition, the itaconate derivatives-treated tumor cells also increased the intracellular GZMB and IFNγ expression, and CD25 expression on T cells in the tumor-T cell co-culture system (Fig. 1E; Appendix Fig. S1C,D). This evidence concerns the gene IFNG and neoplasm.